SE7906340L - Farmaceutisk komposition for rektal administration av cefalosporin - Google Patents
Farmaceutisk komposition for rektal administration av cefalosporinInfo
- Publication number
- SE7906340L SE7906340L SE7906340A SE7906340A SE7906340L SE 7906340 L SE7906340 L SE 7906340L SE 7906340 A SE7906340 A SE 7906340A SE 7906340 A SE7906340 A SE 7906340A SE 7906340 L SE7906340 L SE 7906340L
- Authority
- SE
- Sweden
- Prior art keywords
- pharmaceutical composition
- rectal administration
- cephalosporin
- salt
- piperazinylcarboxamido
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 229930186147 Cephalosporin Natural products 0.000 title 1
- 229940124587 cephalosporin Drugs 0.000 title 1
- 150000001780 cephalosporins Chemical class 0.000 title 1
- 150000003839 salts Chemical class 0.000 abstract 2
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 abstract 1
- 125000000066 S-methyl group Chemical group [H]C([H])([H])S* 0.000 abstract 1
- 239000003945 anionic surfactant Substances 0.000 abstract 1
- 239000003613 bile acid Substances 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 239000002736 nonionic surfactant Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP9000178A JPS5517342A (en) | 1978-07-25 | 1978-07-25 | Cephalosporin composition for rectal administaration |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE7906340L true SE7906340L (sv) | 1980-01-27 |
Family
ID=13986352
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7906340A SE7906340L (sv) | 1978-07-25 | 1979-07-24 | Farmaceutisk komposition for rektal administration av cefalosporin |
Country Status (27)
| Country | Link |
|---|---|
| JP (1) | JPS5517342A (en:Method) |
| AU (1) | AU529031B2 (en:Method) |
| BE (1) | BE877831A (en:Method) |
| CA (1) | CA1123738A (en:Method) |
| CH (1) | CH641351A5 (en:Method) |
| CS (1) | CS268651B2 (en:Method) |
| DE (1) | DE2929840A1 (en:Method) |
| DK (1) | DK159136C (en:Method) |
| EG (1) | EG15790A (en:Method) |
| ES (1) | ES482818A1 (en:Method) |
| FI (1) | FI792303A7 (en:Method) |
| FR (1) | FR2433945A1 (en:Method) |
| GB (1) | GB2028655B (en:Method) |
| GR (1) | GR69652B (en:Method) |
| HU (1) | HU180965B (en:Method) |
| IE (1) | IE48602B1 (en:Method) |
| IL (1) | IL57846A (en:Method) |
| IN (1) | IN151264B (en:Method) |
| IT (1) | IT1118900B (en:Method) |
| LU (1) | LU81546A1 (en:Method) |
| NL (1) | NL7905708A (en:Method) |
| NO (1) | NO792443L (en:Method) |
| NZ (1) | NZ191053A (en:Method) |
| PH (1) | PH16496A (en:Method) |
| PT (1) | PT69969A (en:Method) |
| SE (1) | SE7906340L (en:Method) |
| ZA (1) | ZA793734B (en:Method) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4760059A (en) * | 1985-08-05 | 1988-07-26 | Hoffmann-La Roche Inc. | Rectal dosage form |
| AT392906B (de) * | 1987-10-08 | 1991-07-10 | Hoffmann La Roche | Pharmazeutische praeparate zur oralen verabreichung |
| US5190748A (en) * | 1988-11-22 | 1993-03-02 | Hoffmann-La Roche Inc. | Absorption enhancement of antibiotics |
| KR100739830B1 (ko) * | 2001-03-23 | 2007-07-13 | 주식회사 하원제약 | 세파로스포린 유도체의 제조방법 |
| US8075910B2 (en) | 2004-05-20 | 2011-12-13 | Pbm Pharmaceuticals, Inc. | Oral compositions comprising edible oils and vitamins and/or minerals and methods for making oral compositions |
| CN113637026A (zh) * | 2020-05-11 | 2021-11-12 | 承德医学院 | 一种头孢哌酮镁化合物、其制备方法及应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS4950119A (en:Method) * | 1972-09-21 | 1974-05-15 | ||
| JPS5538925B2 (en:Method) * | 1973-11-08 | 1980-10-07 | ||
| GB1508071A (en) * | 1976-01-19 | 1978-04-19 | Toyama Chemical Co Ltd | Cephalosporins and process for producing the same |
| JPS5244222A (en) * | 1975-09-30 | 1977-04-07 | Yamanouchi Pharmaceut Co Ltd | Method of making insulin preparations for rectal application |
| JPS5822006B2 (ja) * | 1975-12-12 | 1983-05-06 | 萬有製薬株式会社 | チヨクチヨウトウヨヨウセフアトリジンセイザイノ セイゾウホウ |
| JPS6055486B2 (ja) * | 1976-02-28 | 1985-12-05 | 富山化学工業株式会社 | β−ラクタム環を有する化合物の直腸投与用組成物 |
| JPS52156918A (en) * | 1976-06-21 | 1977-12-27 | Sumitomo Chem Co Ltd | Preparation of penicillin pharmaceuticals for rectal infusion |
| JPS5619847A (en) * | 1979-07-25 | 1981-02-24 | Hitachi Ltd | Manufacturing process for discharge lamp |
-
1978
- 1978-07-25 JP JP9000178A patent/JPS5517342A/ja active Pending
-
1979
- 1979-07-16 GB GB7924710A patent/GB2028655B/en not_active Expired
- 1979-07-18 CA CA332,022A patent/CA1123738A/en not_active Expired
- 1979-07-18 NZ NZ191053A patent/NZ191053A/xx unknown
- 1979-07-20 ZA ZA00793734A patent/ZA793734B/xx unknown
- 1979-07-20 IL IL57846A patent/IL57846A/xx unknown
- 1979-07-20 IN IN747/CAL/79A patent/IN151264B/en unknown
- 1979-07-21 EG EG439/79A patent/EG15790A/xx active
- 1979-07-23 DK DK310079A patent/DK159136C/da not_active IP Right Cessation
- 1979-07-23 CH CH680379A patent/CH641351A5/de not_active IP Right Cessation
- 1979-07-23 FI FI792303A patent/FI792303A7/fi not_active Application Discontinuation
- 1979-07-23 HU HU79TO1112A patent/HU180965B/hu unknown
- 1979-07-23 FR FR7918926A patent/FR2433945A1/fr active Granted
- 1979-07-23 GR GR59674A patent/GR69652B/el unknown
- 1979-07-23 DE DE19792929840 patent/DE2929840A1/de active Granted
- 1979-07-24 LU LU81546A patent/LU81546A1/fr unknown
- 1979-07-24 ES ES482818A patent/ES482818A1/es not_active Expired
- 1979-07-24 PH PH22810A patent/PH16496A/en unknown
- 1979-07-24 PT PT69969A patent/PT69969A/pt unknown
- 1979-07-24 CS CS795161A patent/CS268651B2/cs unknown
- 1979-07-24 SE SE7906340A patent/SE7906340L/ not_active Application Discontinuation
- 1979-07-24 NO NO792443A patent/NO792443L/no unknown
- 1979-07-24 NL NL7905708A patent/NL7905708A/nl active Search and Examination
- 1979-07-24 IT IT49844/79A patent/IT1118900B/it active
- 1979-07-24 AU AU49191/79A patent/AU529031B2/en not_active Expired
- 1979-07-27 BE BE0/196403A patent/BE877831A/fr not_active IP Right Cessation
- 1979-08-08 IE IE1411/79A patent/IE48602B1/en not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK39083A (en) | 7-[α-OXIMINO-α-(2-AMINOTHIAZOL-4-YL) ACETAMIDO] CEPHALOSPORANIC ACID DERIVATIVES | |
| SE8202961L (sv) | Cefalosporinderivat och forfarande for deras framstellning | |
| SE7704739L (sv) | Antibacterial agents | |
| DK77981A (da) | Cephalosporinderivater samt fremgangsmaade til fremstilling deraf | |
| MY106038A (en) | 4-quinoline carboxylic acid derivatives useful as immunosuppressive agents. | |
| SE7906340L (sv) | Farmaceutisk komposition for rektal administration av cefalosporin | |
| KR900007412A (ko) | 약제학적 조성물 | |
| DZ1324A1 (fr) | Dérivés de céphalosporine, procédé pour leur préparation compositions pharmaceutiques les contenant et leur utilisation dans le traitement d'infections bactériennes. | |
| SE8104771L (sv) | Cefalosporinderivat | |
| KR910005871A (ko) | 세팔로스포린계 주사용 제제 | |
| SE8704979L (sv) | Nya furanuronsyraderivat, forfarande for deras framstellning och deras anvendning | |
| SE8500965D0 (sv) | Mellanprodukter for framstellning av beta-laktamasinhibitorer | |
| NL7902784A (nl) | Nieuwe cefalosporineverbindingen van 7-(2-(2-amino-4- -thiazolyl)2-(carboxymethoxyimino)aceetamido) 3-gesub- stitueerd cefalosporaanzuur, werkwijze voor hun berei- ding, hun toepassing als geneesmiddelen en farmacolo- gische samenstellingen, die deze verbindingen bevatten. | |
| NO175637C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive 6-fluor-3,5-dihydroksykarboksylsyrer og derivater derav | |
| DK520787A (da) | Terapeutisk middel indeholdende propentofyllin eller derivater deraf til brug ved behandling af peptisk ulcus | |
| NO159857C (no) | Analogifremgangsm te til fremstilling av terapeutisk aktive cephalosporinderivater i syn-form. | |
| KR840006810A (ko) | 세팔로스포린 에스테르의 제조방법 | |
| SE7707366L (sv) | Forfarande for framstellning av 7alfa-metoxi-cefalosporansyraderivat | |
| NO824304L (no) | Fremgangsmaate for fremstilling av antibakterielle pencillinderivater | |
| SE8404556D0 (sv) | Farmaceutisk komposition | |
| FI830192A0 (fi) | Foerfarande foer framstaellning av penicillinderivat | |
| ATE75746T1 (de) | Cephalosporinderivate und verfahren zu ihrer herstellung. | |
| JPS5236685A (en) | Process for preparation of penicillin or cephalosporin derivatives | |
| DK248787A (da) | 5-(2-(pyrrolidin-1-yl)ethoxy)-p-cymenderivater, fremgangsmaade til fremstilling deraf samt laegemidler indeholdende disse | |
| SE8406171L (sv) | Klorcefadroxilmonohydrat |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NAV | Patent application has lapsed |
Ref document number: 7906340-0 Effective date: 19880927 |